For five years, the Narval MRD has been fitted to more than 10,000 patients in Europe and North America. It has also been extensively researched in clinical trials at leading institutions around the world.
Below is a list of scientific research that has been published recently:
- Vecchierini Multicentric clinical study for abstract click here
- Showed excellent compliance and good efficacy in a real-life setting
- 60% responded to treatment before titration
- 94% of patients had high rates of compliance within six weeks of treatment
- Rapid and significant improvement in sleepiness, quality of life (improved social interactions and self-assessed mental health, decrease in daytime dysfunctions) and sleep quality
- Geraads CPHG multicentric study abstract
- One-year follow up with titration on 129 patients
- Treatment efficacious on respiratory parameters (average AHI from 25 before treatment to eight after one year of treatment) even for severe OSA patients (average AHI from 40 to 9)
- Significant efficacy on sleepiness (Epworth score) and fatigue (Visual Analog Scale)
- Only 6% of patients dropped out of treatment for tolerance issues after 12 months
- Cheze, Navailles Biomechanics study abstract - scroll down for English version
- Biomechanics model to compare impact of Narval device vs. Herbst device on TMJ and mouth opening issues
- Narval had a superior tolerance profile to Herbst based on TMJ contact force, and mouth-opening parameters assessment